Department of Nephrology, The Third Hospital of Hebei Medical University, Shijiazhuang, Hebei, China (mainland).
Department of Nephrology, Bayannur City Hospital, Bayannaoer, Inner Mongolia, China (mainland).
Med Sci Monit. 2019 Feb 25;25:1480-1488. doi: 10.12659/MSM.914799.
BACKGROUND Diabetic nephropathy is a predominant cause of renal failure, which is an important chronic complication of diabetes. Pyridoxamine (PM) has been reported to protect renal tubular epithelial cells against oxidative damage and delay or inhibit the development and generation of glucose-induced renal insufficiency at the early stage of disease. In this study, we attempted to explore the protection mechanism of PM on human proximal tubular epithelial cells (HK-2 cells) induced by high glucose. MATERIAL AND METHODS HK-2 cells were cultivated by high glucose medium in the absence or presence of PM. Cell Counting Kit-8 was used to investigate the most appropriate drug concentration of PM by detecting the cell viability of HK-2 cells. The expression of autophagy-related protein Beclin-1, LC-3II, and p62 was measured by western blot analysis, reverse transcription‑quantitative polymerase chain reaction (RT‑qPCR), and immunofluorescence. The expression and localization of Beclin-1 and p62 were also detected via immunofluorescence. The intracellular reactive oxygen species generation was detected using the reactive oxygen species assay kit. The effects of PM on antioxidant defenses were evaluated with glutathione peroxidase (GPx), manganese superoxide dismutase (MnSOD) activity, and glutathione/glutathione disulfide (GSH/GSSG) ratio. RESULTS High glucose levels were able to upregulate the expression of oxidative stress associated protein and inhibit autophagy‑associated changes verified by western blotting, RT‑qPCR and immunofluorescence. Administration of PM reversed the high glucose‑induced low-expressed Beclin-1 and LC-3II, and overexpressed p62 and intracellular reactive oxygen species levels. Furthermore, non-enzymatic antioxidant defenses and enzymatic antioxidant defenses were turned on by the application of PM. CONCLUSIONS Treatment with PM could reverse high glucose-induced inhibition of autophagy and oxidative stress.
糖尿病肾病是肾衰竭的主要病因,也是糖尿病的一种重要慢性并发症。已报道吡哆胺(PM)可保护肾小管上皮细胞免受氧化损伤,并在疾病早期延迟或抑制葡萄糖诱导的肾功能不全的发展和产生。在这项研究中,我们试图探讨 PM 对高糖诱导的人近端肾小管上皮细胞(HK-2 细胞)的保护机制。
用高糖培养基在有无 PM 的情况下培养 HK-2 细胞。通过检测 HK-2 细胞的细胞活力,用细胞计数试剂盒-8 法研究 PM 的最佳药物浓度。通过 Western blot 分析、逆转录-定量聚合酶链反应(RT-qPCR)和免疫荧光法测定自噬相关蛋白 Beclin-1、LC-3II 和 p62 的表达。通过免疫荧光法检测 Beclin-1 和 p62 的表达和定位。使用活性氧检测试剂盒检测细胞内活性氧的产生。通过谷胱甘肽过氧化物酶(GPx)、锰超氧化物歧化酶(MnSOD)活性和谷胱甘肽/谷胱甘肽二硫化物(GSH/GSSG)比值评估 PM 对抗氧化防御的影响。
高葡萄糖水平能够上调氧化应激相关蛋白的表达,并通过 Western blot、RT-qPCR 和免疫荧光验证抑制自噬相关变化。PM 的给药逆转了高葡萄糖诱导的 Beclin-1 和 LC-3II 低表达,以及 p62 和细胞内活性氧水平的过表达。此外,PM 的应用激活了非酶抗氧化防御和酶抗氧化防御。
PM 的治疗可逆转高葡萄糖诱导的自噬抑制和氧化应激。